James W. Green - 29 Dec 2023 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Role
Chief Executive Officer, Director
Signature
/s/ David Sirois, by power of attorney
Issuer symbol
HBIO
Transactions as of
29 Dec 2023
Net transactions value
-$1,129,824
Form type
4
Filing time
03 Jan 2024, 17:18:19 UTC
Previous filing
21 Aug 2023
Next filing
07 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HBIO Common Stock Tax liability $129,400 -24,187 -0.84% $5.35 2,838,492 29 Dec 2023 Direct F1
transaction HBIO Common Stock Tax liability $153,989 -28,783 -1% $5.35 2,809,709 29 Dec 2023 Direct F1
transaction HBIO Common Stock Tax liability $124,206 -23,216 -0.83% $5.35 2,786,493 29 Dec 2023 Direct F1
transaction HBIO Common Stock Tax liability $279,302 -52,206 -1.9% $5.35 2,734,287 29 Dec 2023 Direct F1
transaction HBIO Common Stock Tax liability $442,926 -82,790 -3% $5.35 2,651,497 31 Dec 2023 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit awards previously granted to the Reporting Person that vested on December 29, 2023.
F2 The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person that vested on December 31, 2023.
F3 Includes (a) 235,427 restricted stock units that will vest in two equal installments on December 29, 2024 and 2025, (b) 52,346 restricted stock units that will vest on December 29, 2024, (c) 484,975 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (d) 1,878,749 shares of common stock beneficially owned by the Reporting Person.